PMS Registry
In order to understand if there is other unknown side effect during the clinical trail, the PMS (Post-Marketing Study) will be conducted to learn more treatment experiences on patients, and collect their information for further study.
No. 9 of IRPMA COP Benchmarks regulates that all PMS shall go through JIRB, IRB or Ethics Committee and must be registered on the website of IRPMA PMS registry system. It is to ensure the studies conducted on patients have been approved by JIRB, IRB and protect patient’s right of privacy. The public can also get the information and objective of the PMS through the registry system.
Company Name
Title of Study
Update Date
AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan 2018-08-03
Astellas Pharma Taiwan, Inc. Non-interventional Study on the Safety and Efficacy of Micafungin for Prevention and Treatment of Fungal Infections in Pediatric Patients in Asia/Oceania – ERADICATE Study 2017-06-07
Daiichi Sankyo Taiwan Non-interventional study on edoxaban treatment in routine clinical practice for patients with non valvular atrial fibrillation in Korea and Taiwan 2017-05-23
Daiichi Sankyo Taiwan Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients with Venous Thromboembolism in Korea and Taiwan 2017-05-23
Pfizer Inc. Health-related quality life and health utility among Taiwanese women with advanced/metastatic breast cancer 2017-04-18
Novartis (Taiwan) Co., Ltd Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk of Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), or Post-essential Thrombocythemia Myelofibrosis (PET-MF) 2017-03-14
Novartis (Taiwan) Co., Ltd A non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment pattern of Secukinumab and current standard of care in patient with chronic plaque psoriasis eligible for systemic treatment in the Asia-Pacific and Middle East regions (REALIA) 2017-02-07
Bayer Taiwan Co., Ltd. EXPERT, EXPosurE Registry RiociguaT in patients with pulmonary hypertension 2017-01-26
Bayer Taiwan Co., Ltd. OPTIMIS - Outcomes of HCC patients treated with TACE followed or not followed by sorafenib and the
influence of timing to initiate sorafenib
2017-01-26
Bayer Taiwan Co., Ltd. RIFTOS - Radioactive Iodine reFractory asymptomatic patients in differentiated Thyroid cancer – an Observational Study to assess the use of MultiKinase Inhibitors 2017-01-26
   1 2 3 4 5